ISPOR–THE PROFESSIONAL SOCIETY FOR HEALTH ECONOM..

ISPOR Europe 2024

 

17-20 November Barcelona
Close
N. Poster
Poster title
Applicant name
Status
  1-SA Systematic Literature Review of the Humanistic Burden of Hemophilia A and B Caitlyn Matuska Received Received
  1-RWD A Global Data and Secured Data Environment Technology Framework to Support Healthcare Decision-Making with Real-World Data Bettina Taxell Received Received
  1-OP Electroencephalogram (EEG) Cup Electrode Application: A Multicenter Prospective Study David Hoffman Received Received
  2-MT Real-World Evidence (RWE) in Action: A Review of Australias Health Technology Assessment (HTA) of Non-Drug Health Technologies Jasmine Watson Received Received
  2-HTA Developing a System-Centric Framework for Health Technology Value Creation Caitlin Main Received Received
  3-OP Development of a Taxonomy Tool for Standardising HTA Terminology within SUSTAIN-HTA Saif Elayan Received Received
  3-HSD Real-World Treatment Patterns in Sickle Cell Disease (SCD) in Europe, Africa, Eastern Mediterranean Region (EMR), and India: A Systematic Literature Review (SLR) sarah ronnebaum Received Received
  3-PCR The Psychosocial Burden of Severe Hypoglycemic Events and Impaired Awareness of Hypoglycemia in Adult Continuous Glucose Monitor Users: Results From a Cross-Sectional Survey Study Zara Petzoldt Received Received
  3-CO Minimal Residual Disease in Untreated, Physically Fit Chronic Lymphocytic Leukemia (CLL) Patients (Fit Subpopulation): Results of a Systematic Review With Bayesian Network Meta-Analysis Anita Stozek-Tutro Received Received
  4-MT Improving Patient Access to Care: Single-Use Rhinolarygnoscopes Implemented in SLP Practice Ian Haislip Received Received
  4-CO The True Value of Living Systematic Reviews (LSRs): A Case Report Within Systemic Lupus Erythematosus (SLE) Colleen Dumont Received Received
  5-HPR Visualizing Reimbursement Criteria for Digital Health Tools in Belgium and France Barbara Dhaene Received Received
  5-PCR Patient Perspective About Perceived Impact and Quality of Life in Chronic Kidney Disease Ana Rita Pedro Received Received
  5-RWD Perspectives on Disease Burden Among Informal Care Partners of People With Mild Cognitive Impairment or Dementia Due to Alzheimers Disease: A Real-World Survey Diego Novick Received Received
  5-EPH The Burden of Severe Symptomatic Aortic Stenosis in Spain: Can Capacity-Enhancing Innovations Play a Role in Addressing the Growing Demand for Treatment? Archita Sarmah Received Received
  6-OP Analysis of Pharmaceutical Company Actions in Asia-Pacific to Improve Patient Access Jasmine Watson Received Received
  6-MSR Descriptives vs Statistics in Utility Analyses: A Simulation Colleen Dumont Received Received
  7-RWD Real-World Data Sources for Oncology in Five Major European Countries: A Targeted Literature Review Eric Meadows Received Received
  8-HPR The Payment for Performance Environment for Drugs and Medical Devices in Romania Ciprian Paul Radu Received Received
  9-MSR Meta-Analysis of Pre-Post Studies: Why Standardized Mean Difference Should be Avoided Caitlyn Matuska Received Received
  10-HPR Assessing the Pricing Trends of Repurposed Medicines in the United Kingdom Cillian Copeland Received Received
  10-HSD Reimbursement of Remote Health Services in Turkiye hande can Received Received
  10-HTA HTA Considerations for Large Language Models in Healthcare Caitlyn Matuska Received Received
  10-PCR Humanistic Burden of Radical Cystectomy (RC) Among Patients With Non-Muscle Invasive (NMIBC) or Non-Metastatic Muscle Invasive Bladder Cancer (MIBC): A Systematic Literature Review (SLR) Colleen Dumont Received Received
  10-CO Characterizing the Burden and Unmet Need of Membranous Nephropathy Jasmine Watson Received Received
  10-MT Coverage With Evidence Development as a Potential Solution for the Reimbursement of Digital Therapeutics (DTx)? A Systematic Review of Pathways to Inform Reimbursement Decisions in Major European Healthcare Systems Roman Spelsberg Received Received
  11-CO Delayed Graft Function: More Than Just a Kidney Transplant Complication? Jasmine Watson Received Received
  11-HTA Early Access Programs (EAPs) in France: Reasons for Refusal Gavin Outteridge Received Received
  11-SA A Targeted Literature Review of the Clinical and Humanistic Burden of Polymyalgia Rheumatica and the Associated Unmet Medical Needs Sarah Jane Mckenna Received Received
  11-PT Authoring of Peer-Reviewed Articles on the Experiences of Patients With Rare Diseases by Patients and Their Caregivers: A Rapid Review Kawthar Nakayima Received Received
  11-MT The Impact of High-Plex Point-of-Care Diagnostic Testing for Acute Respiratory Tract Infections in German Emergency Departments: An Early Cost-Consequence Analysis sophie vandepitte Received Received
  12-MT Developing and Applying Predictive Models to Identify Patients at Increased Risk of Falling in Domiciliary Care Tomas Heger Received Received
  12-EE Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Protection of Infants in the United States (US) Ahuva Averin Received Received
  12-CO Predictors of Treatment and Recovery Among Obese Patients in the United States: A Retrospective Observational Study Using the PINC AI Healthcare Database (PHD) Gui Lopes Received Received
  12-RWD Next Generation RWE: What Factors Are Essential to Fully-Federated and AI-Enabled RWE and Outcomes Research? Dustin O Dell Received Received
  13-HSD Patient Characteristic, Treatment Pattern, and Healthcare Resource Utilization of Obstructive Hypertrophic Cardiomyopathy (HCM) in China on a Cardiologist Survey Joanne Wu Received Received
  13-SA A Non-Systematic Review of Equity in Oncology HTA Submissions to NICE Kathleen Bowes Received Received
  14-EPH Gastrointestinal Endoscopy Volume, Efficiency, and Safety Issues: A Case Report David Hoffman Received Received
  14-MT Reusable Flexible Bronchoscope Setup and Reprocessing: A Multicenter Prospective Study David Hoffman Received Received
  14-HSD Understanding Physicians Decision Making Processes When Treating Mild -to-Moderate Chronic Kidney Disease: A Qualitative Study Keila Meginnis Received Received
  15-OP Evaluating the Economic Impact of Real-World Costs in nAMD Treatment Using Neutral Theory: A UK Perspective Ravi Jandhyala Received Received
  15-HPR Innovative Rebate Management in Oncology Drug Budgets: Streamlining Operations and Enhancing Financial Efficiency Through Technology in Newfoundland and Labradors Cancer Care Program Ina Hasani Received Received
  15-PT Utilization Trends and Access Disparities in CAR T-Cell Therapy: Real-World Insights From an All-Payer US Healthcare Database (2017-2024) Gui Lopes Received Received
  15-MT Thought Viruses: A Mental Self-Help App Eva González-Correa Received Received
  15-HTA Oncology Patient and Caregivers Perspectives on Value Assessment Frameworks: A Qualitative Study Colleen Cuthbert Received Received
  15-PCR Exploring the Development, Evaluation, and Impact of Researcher-Led Patient and Family Advisory Councils in Cancer Research Christie Farrer Rogers Received Received
  15-RWD Densifying the Patient Journey by Integrating Data of Oncology Patients From Multiple Data Sources Through Confidential Computing Holger Gothe Received Received
  16-HPR Performance Indicators for the Assessment of Ageing-in-Place Reform Policies: A Scoping Review and Evidence Map Isabelle Vullings Received Received
  16-SA Automating Systematic Literature Review Abstract Screening Using Large Language AI Models: A Development and Validation Study Maisie Borrows Received Received
  16-MT Contrasting Evidence Requirements for Early Access Schemes for Digital Health Technologies in the UK and Germany: A Challenge for Multi-Market Evidence Generation Planning Jasmine Watson Received Received
  16-PCR Does Baseline Disease Severity Impact the Meaningful Score Difference of Clinical Outcome Assessments? Results From Studies in Two Itching-Related Skin Conditions Carla Dias-Barbosa Received Received
  17-EPH Targeted Literature Review (TLR) on the Mortality in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) in the USA Ali Siddiqui Received Received
  17-MT Assessing the Value of Switching Dialysis Center to a Central Delivery System With 220L Drum: A Kingdom of Saudi Arabia (KSA) Case Study Jovana Petrovic Received Received
  17-MSR Can Machine Learning Support Survival Model Selection to Inform Economic Evaluations? Exploring K-Fold Cross Validation Based Model Selection in Seven Datasets Sabine Grimm Received Received
  18-MSR Exploring the Sensitivity of Utility Scores Predicted by the EQ-5D, SF-6D, HUI3, 15D, AQoL4D and AQoL8D Multiattribute Utility Instruments to SF-36 Dimensions Josephine Tetteh Received Received
  18-EPH Assessment of Cardiovascular Events in Patients With Severe COPD Exacerbations Ali Siddiqui Received Received
  18-SA Determining If Delphi Panel Qualitative Insights Can Be Useful When Informing Drug Pricing Related Decisions in the Drug Development Stage Jasmine Watson Received Received
  19-RWD Assessing the Ability of Hospital Sites From a European Real-World Network to Support Oncology Evidence Generation Adil Ajmal Received Received
  19-OP Assessing the Application of Artificial Intelligence Techniques for Systematic Reviews and Meta-Analyses Xuan Wang Received Received
  19-EPH Ovarian Cancer Age-Adjusted Mortality Rates in Chile During 2002-2019 Abbas Ali Received Received
  19-PCR Evaluating the Treatment Patterns Among Patients With Non-Valvular Atrial Fibrillation (NVAF) Prescribed Apixaban or Warfarin by Race/Ethnicity in Commercially Insured Patients Using Komodo Healthcare Map Data Julie Wojciechowski Received Received
  19-MSR Capturing Real-World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for Informed Healthcare Decisions? Kristen Cribbs Received Received
  19-SA Improving Real-World Evidence on Shared Decision Making Through Joint Clinician and Patient Reported Outcomes Maureen Carlyle Received Received
  20-HPR Collaborative Demonstration Project in the Province of Québec for the Operationalization of Value-Based Agreement: Moving From a Vision to Implementation Julie Frappier Received Received
  20-RWD The Use and Validation of Oncology Endpoint Proxies in Real-World Studies: Targeted Literature Review Mapping 64 Retrospective and Validation Real-World Studies Eleanor Ralphs Received Received
  20-HSD Assessing the Impact of Staff Sentiment in Healthcare on Patient Safety Outcomes Maisie Borrows Received Received
  21-MSR Comparing Methods for eGFR Slope Estimates Among Adult CKD Patients in a UK Electronic Health Record System: Challenges and Opportunities Ling Zhang Received Received
  21-PCR Clinical and Humanistic Burden of People With Severe Hemophilia A Treated With Prophylaxis in Europe: A Longitudinal Analysis From the Chess Studies Charlotte Camp Received Received
  21-EPH Incidence of Lichen Sclerosus in Men: A Systematic Review Immaculate Nevis Received Received
  22-SA Mapping the Landscape of Distributional Cost-Effectiveness Analysis: A Systematic Review of Applications and Methodological Considerations Maisie Borrows Received Received
  23-PCR Approaches to Participant Sampling in In-Trial Interviews Brittany Klooster Received Received
  23-HSD Effectiveness of a Quality Improvement Collaboration With Community Nurses to Reduce Hospital Referrals Due to Tunnelled Haemodialysis Catheter Dysfunction Yasmin Ng Received Received
  23-RWD Addition of Open Administrative Claims Significantly Improves Capture of Mortality in Electronic Health Record (EHR) Focused Real-World Data (RWD) Yanina Natanzon Received Received
  24-PCR Vale Project Vascular Access Life Experience: Experience of Patients With Vascular Access for Hemodialysis Geraldo Tadinho Monteverde Spencer Received Received
  24-HPR Use of Real-World Evidence to Support Regulatory Clearance of a Labeling Revision for Robotic-Assisted Radical Prostatectomy in the United States Liza Gibbs Received Received
  25-CO PRO-WAVE1: Monitoring Patient Reported Outcomes (PROs) in Prostate Cancer Through Wave Health: A Novel ePRO Health Platform Margaret Philen Received Received
  25-EPH US Benchmark Data on Healthcare System Encounter-Related Time Toxicity: Top Conditions at the Population Level JoAnn Krenitsky Received Received
  26-EE Years of Life Lost and Productivity Costs Due to Premature Cancer-Related Mortality in Algeria Bernadette Pöllinger Received Received
  26-CO Encorafenib Plus Binimetinib Versus Dabrafenib Plus Trametinib in First-Line for Patients With Metastatic Non-Small Cell Lung Cancer Harboring BRAF V600E Mutation: Matching Adjusted Indirect Comparison of Pharos and BRF113928 Meriem Boussahoua Received Received
  27-EE A Best Practice Guide to Cost-Effectiveness Modelling of CAR Ts in Large B-Cell Lymphoma Brett Doble Received Received
  27-SA A Non-Systematic Review Evaluating Search Strategies Leveraged in HTA Submissions to NICE Kathleen Bowes Received Received
  27-PCR Utility Estimates for Health-States Associated With Chronic Myeloid Leukemia: A Systematic Literature Review Isabelle Lundqvist Received Received
  28-EPH Revolutionizing Systematic Reviews: The Precision of LLMS in Screening Observational Studies Cheryl Jones Received Received
  28-PCR Clinical and Humanistic Burden in Patients With Chronic Myeloid Leukemia in Early Lines of Treatment: A Literature Review Isabelle Lundqvist Received Received
  28-MT Performance Metrics of a Novel Single-Use Therapeutic Gastroscope David Hoffman Received Received
  28-HTA Insights on Early Access Refusal in France Jasmine Watson Received Received
  29-PT From European Union Joint Clinical Assessments to Local Health Technology Assessments: An Environmental Scan of Methodological Guidance Across Key European Markets Colleen Dumont Received Received
  29-SA Pathways to Value and Impact for Child Health and Wellness Deborah Marshall Received Received
  29-EE Efficiency of Secukinumab vs Adalimumab for Treating Hidroadenitis Suppurativa in Spain Carles Blanch Received Received
  29-MSR Automated Data Extraction Using Artificial Intelligence to Accelerate Systematic Literature Reviews in Rheumatoid Arthritis Mirko von Hein Received Received
  30-PT Navigating the New European Member State Coordination Group on Health Technology Assessment Quantitative Evidence Synthesis Guidelines Victoria Paly Received Received
  31-PCR Is There Enough Focus on Capturing Data From Pediatric Patients and Their Caregivers in Non-Oncology Indications? Jasmine Watson Received Received
  31-MT Comparison of Coverage With Evidence Development Approaches for Digital Health Technologies and Pharmaceuticals Jasmine Watson Received Received
  31-EE A Systematic Literature Review of Economic Burden and Medication Adherence With Subcutaneous Versus Intravenous Oncology Therapies Phillip Sarocco Received Received
  32-MSR Harnessing the Value of External Control Arms Beyond the Oncology and Rare Disease Settings Colleen Dumont Received Received
  32-CO Linguists Perceptions of Human- and Machine-Translated Clinical Outcome Assessment (COA) Wording: A Mixed Methods Study Tim Poepsel Received Received
  32-MT A Comparative Effectiveness Study of Two Narrow Profile Staplers Used in Video-Assisted Thoracoscopic Surgery Lobectomy I-Wen Pan Received Received
  33-EPH Risk Factors for Psoriasis: An Umbrella Review of 12 Published Metanalyses Stacey Chang-Douglass Received Received
  33-RWD Physician Perception of Patient Unmet Needs and Optimism Towards Gene Therapy: Results From a Multinational Real-World Survey Sheena Thakkar Received Received
  34-PCR The Impact of Parastomal Hernia on Quality of Life Using Data From the Cipher Prospective Cohort Study Joel Glynn Received Received
  36-MSR Data Visualization of Completion Rate for PRO Objectives in Oncology Clinical Trials Supporting PRO Estimands Christopher Beard Received Received
  37-EPH Adult Vaccinations in Europe: Unfulfilled Potential Karolina Skora Received Received
  38-HSD Continuity of Medication Care for Cancer Patients Through Outpatient Service Provision in Specialist Practices in Germany Holger Gothe Received Received
  39-EE Cost-Consequence Model Comparing the Originator r-hFSH-alfa and Its Biosimilar for =4 Complete Ovarian Stimulation Cycles During Assisted Reproductive Technology Treatment in Spain, France, and Germany Nany Gulati Received Received
  40-CO Efficacy and Safety of Difelikefalin in Patients Receiving Concomitant Opioid Medication Thilo Schaufler Received Received
  40-SA European Multi-Country Real-World Effectiveness in Oncology Using Physician and Patient Survey Data: What Did We Learn? Marion BONNET Received Received
  41-MT The Diagnostic Accuracy of Ultrasound and Genetic Tests for the Diagnosis of Autosomal Dominant Polycystic Kidney Disease: A Systematic Mapping Review James Fotheringham Received Received
  41-PT Benefits of Inhaled Corticosteroids (ICS) in COPD Maintenance Combinations: Real-World Evidence Using Longitudinal Targeted Maximum Likelihood Estimation Tara Cowling Received Received
  41-HTA The Use of the SF-36v2 Health Survey (SF-36), SF-12v2, and SF-6D in Health Technology Assessments Lauren Crowder Received Received
  42-CO Comparison of Survival Outcomes for 177LuLu-PSMA-617 vs Other Systemic Treatments in Post-Taxane Metastatic Castration-Resistant Prostate Cancer Setting: A Bayesian Network Meta-Analysis Valéry Risson Received Received
  42-PCR Multi-Disciplinary Approach to Develop an Ultra-Rare Disease Decision Aid Jasmine Watson Received Received
  42-RWD Understanding the Treatment Landscape in Mild Cognitive Impairment/Alzheimers Disease Dementia and Physicians Opinions on Future Developments in Disease-Modifying Therapies: A Real-World Survey Diego Novick Received Received
  43-MT HTA Requirements for Medical Technologies in Spain Caitlyn Matuska Received Received
  44-EE The Economic and Environmental Burden of Hydrophilic and Hydrophobic IOLs in the UK Derek OBoyle Received Received
  45-MSR Uptake of Artificial Intelligence in Health Economics and Outcomes Research Zlatko Boni Received Received
  45-RWD Researcher Difficulties Using Secondary Data Sources to Generate Real-World Evidence: Results From an Online Survey David Thompson Received Received
  45-HTA Defining Value in the Mental Illness Space: Is Caregiver Burden Considered in Health Technology Assessments of Treatments for Depression and Schizophrenia? Jasmine Watson Received Received
  46-PT Development of Economic Evaluation Studies (EEs) in Saudi Arabia Yazeed Alkhnizan Received Received
  46-EPH Urate Lowering Therapy in Patients With Subcutaneous Tophi Robert Morlock Received Received
  47-HPR Does Orphan Drug Designation Lead to Reimbursement in EU5? Sofia Huertas Received Received
  47-MT The Evaluation of Surgical Stapling in Robotic Thoracic Procedures: Clinical Outcomes and Resource Utilization I-Wen Pan Received Received
  47-SA Clinical, Economic, and Humanistic Burden of SIDS/SUID in the USA and Europe Stacey Chang-Douglass Received Received
  48-CO Population Impact of Performing HRR Testing for Metastatic Castration-Resistant Prostate Cancer Treatment in the US Neo Su Received Received
  49-CO Evaluating Efficacy and Safety of RNA Therapies Lumasiran and Nedosiran in Patients With Primary Hyperoxaluria Type 1: A Systematic Literature Review Ankit Gupta Received Received
  50-RWD Treatment Patterns and Outcomes of RET Fusion-Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With Selpercatinib in Europe: Interim Results From the SPRINT-RET Study Grace Segall Received Received
  50-MSR Use of a Fine-Tuned, Clinical, Bidirectional Transformer (BERT) Large Language Model (LLM) to Classify the Patient and Caregiver Voice Through Their Social Media Health Posts: An Example in Non-Small Cell Lung Cancer (NSCLC) Ashwin Rai Received Received
  50-EE NICE Cancer Drug Fund Exits: Insights Into the Outcomes of Cancer Drug Fund Reappraisals and the Use of Decision Modifiers Elizabeth Thurgar Received Received
  51-EPH Evaluation of US/European Deprivation Indices Applications in Oncological, Health Economics, and Outcomes Research (HEOR) Studies Jasmine Watson Received Received
  52-HSD Reducing Complications in Patients Living With Type 2 Diabetes by an Optimized Management of Weight and Glycemia and Their Associated Savings Virginia Pascual Received Received
  53-HTA Trends Underlying Positive and Negative Decision-Making for New Oncology Treatments Appraised by the National Institute for Health and Care Excellence (NICE) in 2023 Michael Tang Received Received
  53-EPH The Indirect Costs Related to HPV-Attributable Cancer Mortality in European Countries; Years of Life Lost, and Productivity Costs Ugne Sabale Received Received
  54-HSD Epidemiology, Healthcare Resource Utilization, and Costs of Hemophilia A and B by Treatment Regimen: A Retrospective Claims Data Analysis in Germany From 2016 to 2021 Carolina Schwedhelm Received Received
  54-MT Sleep Quality in Peritoneal Dialysis (PD) Patients and Its Associated Economic Burden for Society Sophie Boeger Received Received
  54-PCR Psychometric Validation and Meaningful Within-Patient Change (MWPC) Thresholds for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) Using Data from the EVOKE-01 Study Shanen Stempel Received Received
  55-MSR Is Artificial Intelligence Ready to Tackle Language Barriers for HEOR Research? Danny Yeh Received Received
  55-PCR The Burden of Long COVID on Quality of Life and Daily Functioning Naomi Stapleton Received Received
  55-HTA A Targeted Review of the Challenges and Strategies for Submitting Patient-Generated Evidence to Health Technology Assessment (HTA) Agencies Dorte Katrin Hering Received Received
  56-MT Economic Implications of Response and Non-Response to Cardiac Resynchronization Therapy With Dynamic Atrioventricular Optimization Algorithm Use Zenichi Ihara Received Received
  57-MSR Leveraging Artificial Intelligence for the Generation of Computable Operational Definitions: Facilitating Real-World Evidence Research Evelyn Rizzo Received Received
  59-MT Meek Micrografting in the German Hospital Setting: An Assessment of Recent Developments in Wound Management David Stather Received Received
  59-HSD Addressing Postnatal Depression: Disparities in Treatment Availability Jasmine Watson Received Received
  60-MT Artificial Intelligence-Based Tools Designed to Predict Future Mechanical Ventilation and/or Mortality in Hospitalised COVID-19 Patients: A Systematic Literature Review Harriet Dickinson Received Received
  61-CO Discordance Between Apolipoprotein B and LDL-Cholesterol and Incident Hypertension Risk: An Analysis of US Real-World Data Janna Manjelievskaia Received Received
  61-EPH Sex-Related Disparities in Chronic Cough Reported by Adults in the United States Robert Morlock Received Received
  61-MT Utilizing Single-Use Rhinolaryngoscopes for Fees: A Pre-/Post-Adoption Capability Assessment Ian Haislip Received Received
  61-SA Inequalities by Gender and Overall Index of Multiple Deprivation (IMD) in Accessing Aortic Valve Replacement Remain Remarkable in England Archita Sarmah Received Received
  62-CO Allogeneic Stem Cell Transplantation Rates and Outcomes in Severe Leukocyte Adhesion Deficiency Type I (LAD-I): A Systematic Literature Review Heather Ruffino Received Received
  62-MSR Considerations for Censoring Methods Used to Reconstruct Pseudo Patient-Level Data From KaplanMeier Curves Ioana Gulas Received Received
  63-MSR Prompt Engineering for the Use of Generative Artificial Intelligence (AI) in Health Economic Modeling: Findings From a Targeted Literature Review Jennifer Benner Received Received
  64-CO Systematic Review of Methimazole in Graves Disease Management: Treatment Variations and Efficacy Outcomes Kanupriya Mahajan Received Received
  65-MSR Can Low Effective Sample Size in Matching-Adjusted Indirect Comparisons (MAICS) Lead to Bias? Findings From a Simulation Study Jack Ishak Received Received
  65-HTA Exploring PICO Variations in Relapsed or Refractory DLBCL in the Context of the European Joint Clinical Assessment Sakshi Jindal Received Received
  65-CO Indirect Treatment Comparison of Biologic Treatments in Adolescents With Moderate to Severe Atopic Dermatitis: A Systematic Literature Review and Network Meta Analysis Kevin Li Received Received
  65-HSD Optimizing Management and Outcomes of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) in Spain: BEWAYAPDS Project Kirsten Herrmann Received Received
  66-HPR Readiness Assessment for Cervical Cancer Elimination in Europe Eugenia Karamousouli Received Received
  67-EE Cost-Effectiveness of Pasireotide Long-Acting Release in Acromegaly: Systematic Literature Review Grzegorz Binowski Received Received
  67-MT Cost Analysis and Environmental Impact Estimation of Polypropylene Iodine Contrast Media Containers Compared With Glass Containers: A UK Hospital Perspective Montserrat Chivite Received Received
  68-PCR Preferences in Receiving Clinical Trials Information of Asian, Native Hawaiian, and Pacific Islander Patients With Type 2 Diabetes Mellitus Tetine Sentell Received Received
  68-RWD Is Individual-Patient Data Essential for Transportability, or Can Aggregated Data Suffice? Per-Olof Thuresson Received Received
  68-EPH Introduction of a New Dengue Vaccine (TAK-003) in Brazils Public Health System: Impact on Public Health and Cost-Effectiveness Across Different Age Groups Bruna Mendes da Silva Received Received
  69-MT Next-Generation SequencingBased Circulating Tumor DNA Testing: Clinical Promise Versus Market Access Reality Jasmine Watson Received Received
  70-HSD Budget Impact of a Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia in Australian Public Hospitals mutsa mutowo Received Received
  70-MSR Re-Training of the Artificial Intelligence Tool LiveRefTM: Improved Accuracy and Performance in Data Extraction Colleen Dumont Received Received
  70-HTA Insights into NICEs Approach to Uncertainties in Health Technology Appraisals Smruti Panigrahi Received Received
  71-HTA The Acceptance of Using External Data to Inform Survival Extrapolations for Oncology Health Technology Assessments by NICE Colleen Dumont Received Received
  72-HTA Evolving National Health Technology Assessment (HTA) Frameworks in Theory Versus Practice in the Asia-Pacific (APAC) Region: A Targeted Literature & HTA Review Focusing on Australia, Japan, and Taiwan Jasmine Watson Received Received
  72-RWD The Association of Hemophilia Related Joint Problems, Healthcare Resource Usage, and Patient Adherence to Prophylactic Treatment: Results From a Multinational Real-World Survey Sheena Thakkar Received Received
  73-MSR A Framework for Estimating Quality Adjusted Life Years Using Joint Models of Longitudinal and Survival Data Michael Crowther Received Received
  74-HPR Enhancing the Acceptance of Externally Controlled Trials (ECTs) in the German HTA System: Analysis of Guidance Documents From Other Countries Jörg Tomeczkowski Received Received
  74-PCR Enhancing Patient-Reported Outcome (PRO) Integration in Early Phase Oncology Trials: Navigating Methodological Challenges and Opportunities Andrew BOTTOMLEY Received Received
  75-HTA Payer Perceptions of Health Inequalities in Reimbursement Decision-Making: Results of a Global Survey Tijana Ignjatovic Received Received
  76-PCR Estimating Quality of Life for Systemic Lupus Erythematosus Patients Using aiSLE MGMT: A Smart Disease Management Platform Eldon Jupe Received Received
  76-SA Systematic Literature Review of the Economic Burden of Hemophilia A and B Caitlyn Matuska Received Received
  76-HSD Treatment Utilization and Treatment Duration of Patients With Psoriasis Diagnosed With Psoriatic Arthritis in a US Commercial Administrative Claims Database Jasmine Watson Received Received
  77-EE Optimizing Treatment Pathways for nAMD: Balancing Durability and Costs in the UK Ivan Rickard Received Received
  78-HPR Opportunities and Barriers for the Implementation of Personalized Medicine in Lithuania Kornelija Abromaviciute Received Received
  78-RWD Coverage and Generalisability of Death Data in the DeSC Database in Japan Ayumi Hamaguchi Received Received
  79-MSR Deploy-AI: A Framework and Future Checklist for Facilitating Deployment of Clinical Prediction Models Rehan Alice Received Received
  79-PCR Measuring the Caregiver Burden in Children, Adolescents, and Young Adults With Achondroplasia: Results From a Prospective, Cross-Sectional Study CHRISTINA DUE Received Received
  80-PCR Barriers and Facilitators to the Recruitment and Engagement of Diverse Populations Into Patient Engagement Groups: A Scoping Review Colleen Cuthbert Received Received
  80-RWD Timeline ExplorerIdentifying Time-to-Event Patterns in Real-World Data: An Interactive Open-Source Tool Bruno Casaes Teixeira Received Received
  80-EE Abelacimab for the Treatment of Stroke Prevention in Atrial Fibrillation (SPAF): An Early Cost-Effectiveness Analysis (CEA) Versus Rivaroxaban from 5 European Country Perspectives Jennifer Benner Received Received
  81-RWD Characterization of Adult Patients With Myasthenia Gravis Using French Rare Disease Registry CECILE BLEIN Received Received
  81-CO Pregabalin Utilization and Side Effects Among Hemodialysis Patients Diagnosed With Pruritus or Neuropathic Pain in US Claims Data Thilo Schaufler Received Received
  82-EE The Budget Impact of Introducing a Centralized Point of Care Testing Management System in a Hospital in China xinyue liu Received Received
  83-HTA Assessing Health Technology Assessment (HTA) Outcomes for Conditionally Approved Drugs by the European Medicines Agency (EMA) in Germany, France, and England Alexandra Guyenet Received Received
  83-HPR Adult Vaccination Financing in the EU and UK: A Comparative Perspective Karolina Skora Received Received
  84-HSD Towards a Frictionless CAR-T Therapy Process: Identifying and Prioritizing Procedural Preconditions for Oncologic Institutions Using Group Concept Mapping Ann-Cathrine Froitzheim Received Received
  86-PCR Postnatal Depression: An Underestimated Humanistic Burden in Maternal Health Jasmine Watson Received Received
  86-EPH Increased Healthcare Resources Utilization and Costs of Long COVID in Community-Managed Adult Patients in France Jingyan Yang Received Received
  87-EE A Cost-Benefit Analysis on Digitization of Water Treatment Systems in Renal Care Delivery: The Impact on Organizational, Environmental, and Cost Outcomes Sophie Boeger Received Received
  89-CO Reductions in Concomitant Medication Use and HbA1c Impact Following Initiation of an Advanced Hybrid Closed-Loop System (AHCL) Versus Multiple Daily Injection (MDI) Therapy in People With Type 2 Diabetes (T2D) Janna Manjelievskaia Received Received
  90-EE Cost-Effectiveness of Caplacizumab for Thrombotic Thrombocitopenic Purpura in Brazil Julia Simes Correa Galendi Received Received
  91-PCR Health-Related Quality of Life of Patients With Cushings Disease Treated With Osilodrostat: Mixed-Effects Regression Analysis Grzegorz Binowski Received Received
  91-HPR Price Sensitivity and Uptake of Pharmaceuticals in Sweden and Finland: The Example of New Migraine Drugs Jenny Wiberg Received Received
  92-MSR Validating the AI Assisted Abstract Screening Feature of Nested Knowledge Platform Xuan Wang Received Received
  92-HTA NICEs Severity Modifier: Insights From Recent Appraisals Maisie Borrows Received Received
  92-HSD The Evolution of Single-Use Ureteroscope Use in the United States Ian Haislip Received Received
  93-SA Inclusion of Deadweight Loss in Healthcare Economic Appraisals Cillian Copeland Received Received
  93-HSD The Diagnosis and Management of Uncontrolled and Treatment-Resistant Hypertension: A Targeted Literature Review of Eight Countries Clinical Practice Guidelines James Fotheringham Received Received
  94-HPR Insurance Payments and Hospital Costs Among Patients With S T Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI) in US Hospitals Gui Lopes Received Received
  95-MSR Health Economic Evaluations Incorporating Broader Perspectives: A Targeted Literature Review Stacey Chang-Douglass Received Received
  95-PCR Performance of the EQ-TIPS and PedsQL in Infants and Toddlers With a Health Condition Janine Verstraete Received Received
  95-HTA Predicting Evidence Requirement Implications of the EU Joint Clinical Assessment (JCA) Through a Population, Comparator, Intervention, Outcome (PICO) Simulation for Two Anticancer Investigational Medicinal Products (IMPs) Sundeep Ubi Received Received
  95-EPH The Role of Adjuvant Atezolizumab in Reducing Recurrence-Related Treatment Costs in Resected Early-Stage PD-L1 High Non-Small Cell Lung Cancer in Belgium Liesbet Herteleer Received Received
  96-HPR Price Monitoring of Anticancer Drugs Under Price Controlled Category in India Subhash Mandal Received Received
  97-HPR More Public Funding? A Choice Experiment on the Healthcare Funding System for Older Populations TAKESHI MORI Received Received
  97-CO Characterizing the Burden and Unmet Need of Antibody-Mediated Rejection Jasmine Watson Received Received
  99-HTA Matching Insights From Clinical Experts and Generative AI for JCA PICO Validation Cheryl Jones Received Received
  99-EPH Sepsis Burden in Europes Largest Countries: Hospital-Acquired Cases and Late Diagnosis Impact Michela Canobbio Received Received
  100-EE Economic Burden of High-Risk Localized and Locally Advanced Prostate Cancer in LATAM: Experts Perspective Kim Buscemi Received Received
  100-HTA How Do Abbreviated HTA Submissions Impact Reimbursement? A SMC Case Study Eoin Jennings Received Received
  100-RWD The Impact of COPD Type 2 Inflammation and the Consequences on Outcomes in the Brazilian Private Healthcare System: A Real-World Analysis Ali Siddiqui Received Received
  100-SA Effect of Adherence to Hemophilia Drug Therapy on Outcomes: A Systematic Literature Review Caitlyn Matuska Received Received
  101-EE Cost-Effectiveness Analysis of Second-Line Treatment With Lisocabtagene Maraleucel Versus Standard of Care for Patients With Large B-Cell Lymphoma in the Netherlands Colleen Dumont Received Received
  101-PCR Patient Characteristics Associated With Treatment Preference for Generalized Myasthenia Gravis (gMG): A Multivariate Analysis Kristy Maguire Received Received
  102-EPH Healthcare Utilization Among RTT Patients With Aspiration and Epilepsy in a Center of Excellence Medical Center in the United States Nazia Rashid Received Received
  102-SA Using Retrieval Augmented Generation (RAG) and Agents Workflow for Protocol Authoring Bruno Casaes Teixeira Received Received
  103-EPH Incidence of Solar Retinopathy and Photokeratitis in Private Clinic Post 2017 and 2024 Solar Eclipses Across the USA Nick Boucher Received Received
  103-HSD Scoping Review on Attitudes and Barriers Towards Therapeutic Drug Monitoring for Biological Treatments for Immune-Mediated Inflammatory Diseases Among Key Stakeholders Olga Pitsillidou Received Received
  103-CO Characteristics of Patients With Ehlers-Danlos Syndromes (EDS): Analysis of US Real-World Data Janna Manjelievskaia Received Received
  104-HTA Equity Is Not Equal: A Comparative Study of How Equity Is Considered by NICE, ICER, CDA-AMC, and PBAC Maisie Borrows Received Received
  104-MSR Applications of Bayesian Borrowing for Assessing Treatment Effects in Clinical Trials Colleen Dumont Received Received
  105-PCR Impact of CAR T-Cell Therapy on Health Utilities for Patients Diagnosed With Diffuse Large B-Cell Lymphoma in Canada Lisa Masucci Received Received
  105-RWD Dosing Schedules and Concomitant Medication Usage in Patients With Generalized Myasthenia Gravis Treated With Ravulizumab or Efgartigimod Kristy Maguire Received Received
  105-CO Impact of Glucagon-like Peptide 1 Receptor Agonist (GLP-1 RA) Non-Persistence on Body Mass Index, HBA1C, and Lipids: Analysis of Over 190,000 Adults Treated With Semaglutide, Liraglutide, and Tirzepatide in US Real-World Data Janna Manjelievskaia Received Received
  105-HSD Treatment Strategies for Uveal Melanoma: A Systematic Review Rishabh Verma Received Received
  106-HSD Influence of Initial Imaging Type on Time-to-Diagnosis Among Cancers Without Routine Screening Programs: A Seer-Medicare Study Xiting Cao Received Received
  106-HTA How Has Treatment Switching Been Accounted for? Insights From NICE Appraisals Jasmine Watson Received Received
  107-HPR The Devil in the Detail: The Challenges of Evaluating Patient Access to Medicines Jasmine Watson Received Received
  108-HTA Artificial Intelligence Tools for PICO Prediction: A New Reality or a Future Dream? Paulina Rolska-Wójcik Received Received
  108-SA Clinical and Humanistic Burden of Giant Cell Arteritis and the Associated Unmet Medical Needs: A Targeted Literature Review Sarah Jane McKenna Received Received
  108-HSD Impact of Predictive Modelling and Application of Preventative Measures in Reducing Fall Rates in Domiciliary Care Tomas Heger Received Received
  110-HSD Statin Prescribing in Patients With Non-Alcoholic Steatohepatitis in the United States: An Analysis of 3 Real-World Data Sources Yestle Kim Received Received
  111-CO Indirect Treatment Comparisons of Lefamulin Versus Omadacycline for the Treatment of Community-Acquired Pneumonia Joanne Wu Received Received
  111-SA Utility of SNOMED CT Vs ICD-10-CM Diagnosis Codes in Identifying Common, Rare, and Ultra-Rare Disease in a Large, Ambulatory Electronic Health Records Database Janna Manjelievskaia Received Received
  112-SA Machine Learning and Artificial Intelligence for Supporting Systematic Reviews: A Systematic Review of Recent Methodological Developments and Recommendations for Implementation Caitlyn Matuska Received Received
  112-PCR A Time Trade-Off Study to Develop Health-Related Utility Data for the Impact of Geographic Atrophy on Patients Michele Intoricia Received Received
  113-EE Follitropin Delta Is Cost-Effective Versus Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France Marie Markert Received Received
  114-CO A Systematic Literature Review (SLR) of the Clinical Efficacy and Safety Evidence Associated With Treatments for Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) Who Progressed on Prior Therapies Shanen Stempel Received Received
  114-HTA Characterizing Oncology Outcomes in Canadas Drug Agency (CDA-AMC) Reviews From 2022 -2023 Trisha Whitney Received Received
  114-PCR Modelling the Benefit of Givinostat on Duchenne Muscular Dystrophy (DMD) Patients, and Their Caregivers Natalia Arrabal Received Received
  116-MSR Artificial Intelligence (AI)-Assisted Early Data Insights and Literature Monitoring: A Case Study of Maintaining an Up-to-Date Reference Library in Metastatic Prostate Cancer (MPC) Colleen Dumont Received Received
  117-PCR Health State Utility Values for Sleep Disturbance and Early Morning Off Symptoms in Advanced Parkinsons Disease: A Vignette-Based Approach Using the EQ-5D Pablo Arija Prieto Received Received
  118-PCR Impact of SHE Frequency and IAH Status on Sleep Quality in Adult Continuous Glucose Monitor Users With Type 1 Diabetes: Results From a Cross-Sectional Survey Study Zara Petzoldt Received Received
  118-CO Indirect Treatment Comparison (ITC) of Avalglucosidase Alfa (AVA) vs Cipaglucosidase Alfa Plus Miglustat (Cipamig) in Late-Onset Pompe Disease (LOPD): An Updated Analysis Using Mixed-Model Repeated Measures (MMRM) Data Mau Sinha Received Received
  118-RWD Rare-Xtract: A Hybrid Pipeline for Generating Real-World Data Products From Unstructured Electronic Medical Records (EMRs) of Rare Diseases Leveraging Natural Language Processing (NLP) and Keyword Extraction Techniques Alva James Received Received
  119-CO Methodological Considerations for Time-to-Event Analyses of Non-Interventional Studies (NIS) Collecting Real-World Data (RWD) Prospectively: A Simulation Study Hamid Mahmoudpour Received Received
  120-RWD Leveraging the DeSC Database for Alzheimers Disease Research in an Aging Population in a Real-world Setting in Japan Ayumi Hamaguchi Received Received
  120-MSR Quantifying Health Related Quality of Life Benefits From Patients Treated With Mavacamten for Obstructive Hypertrophic Cardiomyopathy (HCM) in China Based on the EXPLORER-CN Trial JIA YU Received Received
  120-EE Factors Associated With the Inclusion of Societal Costs in Published Cost-Effectiveness Analyses, 2013-2022 Meng Li Received Received
  120-HTA Interpreting the Non-Inferiority Evidence in NICE Streamlined Cost-Comparison Appraisals Carina Marie Behr Received Received
  121-HTA Improving Literature Review Efficiency: Evaluating the Impact of the Opensource Asreview Tool on Time and Effort to Conduct Systematic and Targeted Reviews Nicole Tunstall Received Received
  121-SA Can Living Systematic Literature Reviews Reduce Research Wastage? An Evaluation of LiveSLR Colleen Dumont Received Received
  121-PCR Can You Feel the Tension? Evaluating the Translatability of Complex Terminology in PROs Tim Poepsel Received Received
  122-EPH Understanding the Patient Journey of Lung Cancer Patients in China: A Multi-Center Study Sean Kao Received Received
  125-RWD Identifying Fit-for-Emulation Data: Adaptation of a Structured Data Feasibility Assessment Process for Real-World Oncology Trial Emulations Adina Estrin Received Received
  125-EE Cost-Effectiveness of Targeted Newborn Screening for Congenital Cytomegalovirus Infection in Japan MOTOKO TANAKA Received Received
  125-PCR Assessing the Relationship Between EQ-5D-3L Index Scores and Disease-Specific Patient-Reported Outcome Measures in Eosinophilic Oesophagitis Ali Siddiqui Received Received
  125-EPH How Do We Refer to Individuals in the Scientific Literature? Use of Person-First Language vs Condition-First Language in Oncology Medical Journals Agnes Williams Received Received
  126-RWD Clinical Characteristics and Frailty of Patients With Mild Cognitive Impairment or Dementia Due to Alzheimers Disease: A Real-World Survey Diego Novick Received Received
  127-PCR Persons With Dementia From a Migration Background and Informal Caregivers Prioritizing Their Aging-in-Place Care Preferences: A Mixed Methods Study Soukaina el Jaouhari Received Received
  127-EE Economic Evidence Associated With Treatments for Patients With Non-Small Cell Lung Cancer (NSCLC) Who Progressed on Prior Therapies: A Systematic Literature Review (SLR) Shanen Stempel Received Received
  128-PCR Health-Related Quality of Life of Patients With Charcot-Marie-Tooth Disease: A Systematic Review Sukannya Mahapatra Received Received
  128-RWD A Real-World Data Landscape Review of the 2023 International Society for Pharmacoeconomics and Outcomes Research Europe Conference Deb Casso Received Received
  129-HPR An Umbrella Review of the Impacts of Climate Change on Maternal Health and Birth Outcomes Colleen Dumont Received Received
  130-PCR Health-State Utility Values and Their Time to Deterioration in Informal Caregivers of Elderly Patients With Chronic Diseases Taha JAI Received Received
  130-HTA Key Drivers Underlying Positive and Negative Decisions for National Institute for Health and Care Excellence (NICE) Technology Appraisals (TAS) and Highly Specialised Technology (HST) Appraisals in 2023 Michael Tang Received Received
  130-CO Outcomes and Economic Effects of Digital Health Services: An Umbrella Review Elina Laukka Received Received
  131-EE Systematic Review of Cost-Effectiveness Modelling Studies for Haemophilia Niklaus Meier Received Received
  131-CO Comparative Efficacy of Elafibranor and Seladelpar in Patients With Primary Biliary Cholangitis: A Network Meta-Analysis Shimaila Siddiqui Received Received
  131-MSR Effective Outcome Measures for Family Caregivers of Patients With Alzhemers Disease in Japan: Conducting Factor Analysis Using ASCOT-Carer, ZBI, and EQ-5D-5L Tomohiro Kondo Received Received
  132-EPH Inadequate Response to Therapy Among Ulcerative Colitis Patients Initiating an Advanced Therapy: A Retrospective Analysis of German Health Claims Data Carolina Schwedhelm Received Received
  133-HPR The Global Impact of EU HTA: Insights From 13 Non-EU Countries Maria João Garcia Received Received
  133-EE Cost-Effectiveness of Intensive and Local Neonatal Care Units in England: A Real-World Evidence Analysis of a National Birth Cohort Oliver Rivero-Arias Received Received
  136-MSR Feasibility of GPT-4-based Content Extraction to Identify Eligible Titles and Abstracts in a Systematic Literature Review Lalith Mittal Received Received
  136-CO Chemoimmunotherapy With Dinutuximab Beta Compared to Chemotherapy Regimens in Patients With Relapsed/Refractory Neuroblastoma: Systematic Literature Review and Indirect Treatment Comparison Grzegorz Binowski Received Received
  137-MSR The Impact of Censoring Assumptions on STC-Adjusted Simulated Time-to-Event Data Colleen Dumont Received Received
  137-HPR Evaluating the Clinical and Socioeconomic Impact of Improved CKD Diagnosis and Adherence to Guideline-Directed Medical Therapy in Australia, Brazil, and China: An Impact CKD Analysis Trisha Whitney Received Received
  137-HSD The Value Proposition of Remote Monitoring in Heart Failure: Pains and Gains Towards Patients Adoption Robert Menkveld Received Received
  138-PCR Inequalities in the Impact of Dermatological Diseases Across the Globe: Impact Results From the GRIDD Study Allison FitzGerald Received Received
  139-EPH Prevalence and Disease Burden of Disease-Related Malnutrition in Hospitalized Patients in Spain Esteban Lifschitz Received Received
  139-RWD Characteristics of Ovarian Cancer Patients: A Real-World Perspective for 1st Line Maintenance Treatment Choice After 1st Line Platinum Based Induction Therapy Across EU4 & UK Karina Palhares Received Received
  142-EE Alectinib, Brigatinib, and Lorlatinib As First-Line Therapies for Advanced ALK-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis Rahul Mudumba Received Received
  143-RWD Caregiver Burden Among Patients With COVID-19: A Systematic Literature Review of Real-World Evidence Shailja Vaghela Received Received
  144-MSR Group-Based Trajectory Modelling Considerations: Learnings from a Published Application in Acute Myeloid Leukaemia Emily Aiello Received Received
  144-EE The Budget Impact of Cangrelor for the Treatment of Patients With Gastric Absorption Issues Undergoing Percutaneous Coronary Intervention in the UK richard stork Received Received
  145-HTA Qualitative and Quantitative Evidence Synthesis Strategies to Support JCA and IRA Submissions Caitlyn Matuska Received Received
  145-EE Evaluating the Cost-Efficacy of Calcipotriol Plus Betamethasone Dipropionate Cutaneous Pad Cream for the Topical Treatment of Mild to Moderate Plaque Psoriasis in Italy Rituparna Banerjee Received Received
  145-PCR Evaluating the Impact of the Cionic Neural Sleeve on Quality of Life in Multiple Sclerosis Patients: A Pilot Study Bruce Wang Received Received
  146-MSR Deriving an Analytical Solution to Inversion of Royston/Parmar Restricted Cubic Spline Parametric Survival Models for Discrete Event Simulation George Bungey Received Received
  146-EPH Progression to Metastatic Breast Cancer According to Stage and Biomarker Status at Diagnosis in Denmark: A Register-Based Cohort Study Jenny Wiberg Received Received
  147-RWD Development of a US-Based, Real-World, Ophthalmology Registry Based on Automated EHR Data Extraction to Support Opportunities for Clinical and Health Economics and Outcomes Research in Eyecare Nick Boucher Received Received
  149-PCR Burden of Childhood Arthritis: Work Productivity Loss and Activity Impairment of Parents and Caregivers Deborah Marshall Received Received
  150-RWD First Patient Enrolled in Pilot Phase of the Economics and Patient Outcomes in China in Hemophilia (EPOCH) Study Elizabeth Clearfield Received Received
  151-CO Overall Survival of Patients With Large B Cell Lymphomas in Poland After Chimeric Antigen Receptor T Cell (CAR-T) Therapies Compared to the Real-World Evidence From Other Countries Grzegorz Binowski Received Received
  152-CO Simulation of Long-Term Impact of Bempedoic Acid and Ezetimibe on Atherosclerotic Cardiovascular Disease Outcomes in Europe Caitlyn Matuska Received Received
  153-HTA Health Equity Priorities for Pharmaceutical Manufacturers: Payer Perceptions From a Global Survey Tijana Ignjatovic Received Received
  156-HTA Assessing the Generalizability of Automating Adaptation of Excel-Based Cost-Effectiveness Models Using Generative AI Cheryl Jones Received Received
  157-RWD A Real-World Study of Multiple Myeloma Patients With at Least 3 Prior Treatment Lines and Triple Class Exposed Disease in Finland: Outcomes and Need for Healthcare Resource Use Akseli Kivioja Received Received
  157-EE Economic Burden of Charcot-Marie-Tooth Disease: A Systematic Review Sukannya Mahapatra Received Received
  157-CO Carfilzomib in Combination With Dexamethasone and Daratumumab (KdD) Versus Carfilzomib in Combination With Lenalidomide and Dexamethasone (KRd) in Relapsed and/or Refractory Multiple Myeloma: An Indirect Treatment Comparison Sachin Patel Received Received
  158-PCR Attribute Development and Level Selection for a Discrete Choice Experiment to Elicit Care Preferences of Older Adults and Informal Caregivers Aging in Place in the Netherlands Isabelle Vullings Received Received
  159-EE Cost-Effectiveness of the Personalization of Immunosuppressive Therapy in Kidney Transplantation by Means of an in Vitro Diagnostic Test (IMMUNOBIOGRAM) in Spain Maria Teresa Diez Laplaza Received Received
  159-EPH Estimating the Remaining Chronic HCV Prevalence in Ireland: A Risk Population Modelled Approach Applied in Practice Nic Talbot-Watt Received Received
  160-HPR Integrating Healthcare System Value Into New Medicine Evaluations for Timely and Full Patient Access Jasmine Watson Received Received
  161-CO Use of Generative AI for Rapid and Accurate Extraction of PICOs at Scale Diana Steinway Received Received
  162-CO A Systematic Literature Review to Assess the Variability in Conducting and Reporting of Matching-Adjusted Indirect Comparisons in Chronic Lymphocytic Leukemia: Findings and Implications for EU HTA Varun Ektare Received Received
  164-EPH Clinical and Economic Burden of Obesity Among Hospitalized Patients in the United States Gui Lopes Received Received
  164-PCR Worldwide Longitudinal Observational Study of Fatigue-Related Symptoms in Patients With Relapsing Multiple Sclerosis, Daily Assessment and 7-Day Lookback Gilda Teissier Received Received
  166-PCR Exploring the Content Validity of the EQ-5D-5L and Four Bolt-Ons (Skin Irritation, Self Confidence, Sleep, Social Relationships) in Atopic Dermatitis and Chronic Urticaria Katy Gallop Received Received
  169-MSR Health Technology Decision-Making in an Imperfect World: A Unifying Framework of Value of Information and Implementation Metrics Based on a Narrative Review Sabine Grimm Received Received
  170-EPH Burden of Severe ANCA Associated Vasculitis in Australia via Real-World Usage of Rituximab Scott Brydon Received Received
  170-PCR A Systematic Scoping Literature Review to Identify the Humanistic Burden Attributed to Living With Primary Sjogrens Disease Zlatko Boni Received Received
  171-RWD Leveraging Artificial Intelligence to Enhance the Quality and Efficiency of Real-World Evidence Generation in HEOR Thibaut Vergnol Received Received
  171-HPR Estimating the Impacts of Government-Mandated Price Reductions on Indication Expansion for Launched Drugs: A Real-World Study Jacqueline Rhuda Received Received
  172-CO Characterizing the Burden and Unmet Need of Lupus Nephritis Jasmine Watson Received Received
  172-RWD Optimizing RWE Design and Conduct by Leveraging Computable Operational Definitions Indication Libraries: Development, Verification, and Value Jared Kamauu Received Received
  172-EPH Unmet Needs and Spatiotemporal Variation in Vitiligo: A Retrospective Longitudinal Web Search Analysis Michael Hindelang Received Received
  173-PCR The Geographic Atrophy Long-Term Outcomes Study (GALTOS): Preliminary Analysis of Patient Clinical Characteristics, Retrospective Natural History, and Patient Survey Results Michele Intorcia Received Received
  174-EE Societal Impact Valuation of Axicabtagene Ciloleucel in Diffuse B-Cell Lymphoma in the Netherlands Angela Borghouts- de Ruijter Received Received
  174-PCR Importance of Specific Clinical Trial Enrollment Strategies for Native Hawaiian, Pacific Islander, and Asian Patients With Type 2 Diabetes Mellitus Deborah Taira Received Received
  175-CO Clinical Outcomes of Interventions in Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Systematic Literature Review Isabelle Lundqvist Received Received
  176-HTA Assessing Trends in European Unions Health Technology Assessment Submissions of Antibody-Drug Conjugates Debjit Ghoshal Received Received
  177-EPH A Multimodal Deep Neural Network for Early Prediction and Detection of Alzheimers Disease Based on MRI Images and Clinical Information Xinyao Yi Received Received
  177-HPR Modeled Impact of Risk-Sharing Agreements on Costs for Hemophilia B Gene Therapy in Germany Lasse Falk Received Received
  178-HPR Quantifying Health Inequity: An Umbrella Review of Systematic Literature Reviews on Sex-Based Differences in Health Outcomes Colleen Dumont Received Received
  179-HTA A Targeted Review of Treatment Beyond Progression in NICE HTA Oncology Submissions Colleen Dumont Received Received
  179-MSR Automated Extraction of Cost-Effectiveness Models Data from Health Technology Assessment Submissions Using Large-Language Models (LLMS): Does the Prompting Approach Matter ? Simone Rivolo Received Received
  180-PCR Patterns in Attribute Selection Reporting in Patient Preference Studies: A Systematic Review Rebekah Hall Received Received
  180-MSR Challenges in NMA Methodology Based on Re-Randomization vs Treat-through Trial Designs Susanne Hartz Received Received
  181-PCR Quality of Life and Its Drivers in Patients With Uveal Melanoma: A Systematic Review Rishabh Verma Received Received
  182-HTA Evaluating the Use, Performance, and Acceptability of Utility Measurement Approaches in Geographic Atrophy: A Severe Vision Disorder Emma Williams Received Received
  182-PCR Underestimation of the Burden of Gout Robert Morlock Received Received
  183-RWD How Does Real-World Evidence Support Regulatory and HTA Agency Assessments and Beyond? Jasmine Watson Received Received
  184-PCR Comparing the Humanistic and Economic Impact of Osteogenesis Imperfecta Affected and Non-Affected Caregivers, When Caring for an Individual With Osteogenesis Imperfecta Heather Muhall Received Received
  185-CO Gene Therapies for High-Grade Gliomas and Glioblastomas: A Systematic Review Stacey Chang-Douglass Received Received
  185-EE Assessing the Economic Impact of the Adoption of Digital Single-Use Cholangioscopes for the Treatment of Choledocholithiasis During Laparoscopic Cholecystectomy: A Health Economic Model for Spanish Hospitals Oleksandr Topachevskyi Received Received
  186-HPR Developing a Value Framework to Determine New Drugs Price Premium Using Multi-Criteria Decision Analysis Approach: SFDA Experience Mona Almaghrabi Received Received
  187-MSR Automated Data Extraction in Systematic Literature Reviews (SLRs): Assessing the Accuracy and Reliability of a Large Language Model (LLM) Carolina Casañas i Comabella Received Received
  187-HPR Injectable Oncology Therapies: Benchmarking Gross and Net Price Differentials in Europe vs US Nekshan Dalal Received Received
  187-PCR EQ Health and Wellbeing (EQ-HWB): Assessing the Distinctiveness of Frequency and Severity Response Scales in Measuring Pain and Discomfort Soumana Chamoun Nasser Received Received
  188-RWD Unlocking the Potential of Interoperable Linked Low-Latency National Health Data in England to Protect Vulnerable Patients While Safeguarding Their Privacy: A Brave New World ss ss Received Received
  189-EE Hospitalizations in Patients Receiving Durvalumab Plus PlatinumEtoposide in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: Exploratory Analysis From the Phase IIIb CANTABRICO Study Anisia Martinez Received Received
  189-HPR To What Extent Are Oncology Submissions to the National Institute for Health and Care Excellence (NICE) Incorporating a Probabilistic Base Case? Colleen Dumont Received Received
  191-PCR Counting on Data Validity in Multinational Clinical Trials? Numeral Systems in Patient-Reported Outcome Assessments: Guidance for Linguistic Validation Tim Poepsel Received Received
  191-RWD Real-World Medical Utilization and Outcomes Associated With Treatments for Advanced ALK-Positive Non-Small Cell Lung Cancer Rahul Mudumba Received Received
  191-CO Application of Causal Inference Methods to Assess Efficacy in Secondary Outcomes in Ophthalmology Clinical Trials for Use in Economic Models Michele Intoricia Received Received
  192-PCR Quality of Life and Its Drivers for Patients Living With Angelman Syndrome (AS): A Systematic Review Vyshnavi Telukuntla Received Received
  193-RWD Heterogeneity in Crohns Disease and Ulcerative Colitis Clinical Endpoints Leading to Uncertainties in the Real-World Setting Sabera Hashim Received Received
  193-CO Risk Factors Associated With an Aspiration Outcome in Patients With Rett Syndrome: Analysis of Real-World Data in the United States Nazia Rashid Received Received
  194-EPH Estimating the Prevalence of Controversial Denials of Essential Medicines and Health Services Through Legal Case Review Emily Kelty Received Received
  194-PCR Using Distribution-Based Methods to Determine Minimal Important Differences With the Hypoglycemia Fear Survey-II in Adults With Type 1 Diabetes Zara Petzoldt Received Received
  194-HTA Overview of NICE Cost-Comparison Technology Appraisals: Key Takeaways Regarding Comparator Selection and Methods Used to Demonstrate Comparable Efficacy Jake Astill Received Received
  196-CO Efficacy of Treatments for Pediatric Patients With Relapsed/Refractory High-Grade Glioma: Results From a Systematic Review of the Literature rachid rafia Received Received
  197-HTA Recent Trends From UKs Cancer Drugs Fund, Key Drivers of Acceptance Jasmine Watson Received Received
  199-HPR Impact of the Innovative Licensing and Access Pathway (ILAP) Designation on Regulatory and Health Technology Assessment (HTA) Outcomes Caitlyn Matuska Received Received
  199-EPH Health Impact and Burden of Illness in Immune Thrombocytopenia: A Literature Review on Clinical, Humanistic, and Economic Burden isabelle lundqvist Received Received
  200-EE A Comparison of Outcomes Measures in Cost-Effectiveness Analysis: Three Applications Within Oncology Brian Reddy Received Received
  203-MSR Using Machine Learning to Explore Scientific and Social Media Engagement With Medical Publications Helen Stewart Received Received
  204-MSR Exploration of AI-Tools Used in Systematic Reviews and Evidence Synthesis Immaculate Nevis Received Received
  206-EE Estimation of the Health and Economic Effects of Innovations in Health Care at a Societal Level Guillaume Moukala Same Received Received
  206-HPR Evaluating the Maturity Level of Health Technology Assessment in Latin America: A Comparative Qualitative Analysis Bruno Boietti Received Received
  207-HPR How Long Is Long Enough? Data Collection Duration for Medicines in Managed Access in England Charlotte Bee Received Received
  208-EE Stakeholder Views on the Use and Challenges of Using Economic Evaluations in Health Innovation Development in the Netherlands Chris van Lieshout Received Received
  210-EE Hospitalization Costs of Common Grade 3/4 Adverse Events Associated With Oncology Treatments in the United States: 2024 Update Caitlyn Matuska Received Received
  212-EPH Prevalence of Pulmonary Embolism Among Medicare Enrollees: A Six-Year Perspective Luckyboy Vang Received Received
  214-HTA Trends Underlying Positive and Negative Decision-Making for New Treatments Targeting Rare Diseases (RD) Appraised by the National Institute for Health and Care Excellence (NICE) in 2023 Michael Tang Received Received
  215-HTA Targeted Review: Generalizability of Clinical Trial Evidence to the Patient Population in NICE Technology Appraisals Isobel Thornton Received Received
  215-PCR PRO Gap Analysis in Antibody Mediated Rejection, Delayed Graft Function, Lupus Nephritis, and Membranous Nephropathy Jasmine Watson Received Received
  219-HTA Transporting Real-World Evidence: Is It Possible to Transport OS Estimates in HER2 mBC From US to UK? Darren Johnson Received Received
  219-MSR Can Artificial Intelligence (AI) Accurately Screen Abstracts in Systematic Literature Reviews? Noemi Hummel Received Received
  220-HTA AI-Assisted Review of NICE Guidance for Highly Specialized Technologies: Economic Modelling of Ultra-Rare Conditions Stacey Chang-Douglass Received Received
  221-EE The Willingness to Pay Threshold in the Netherlands: Time for an Update! Angela Borghouts- de Ruijter Received Received
  221-HPR Revisiting Healthcare Resource Allocation for Immunotherapeutic Treatments in Cancer Hamideh Mahdiani Received Received
  224-HPR Utilization of Long-Term Care Before and After the 2015 Dutch National Reform: An Interrupted Time Series Analysis Janet MacNeil Vroomen Received Received
  224-HTA A Roadmap to the Use of Value of Information Analysis in Health Technology Assessment: An International Study of Barriers, Facilitators, and Potential Applications Sabine Grimm Received Received
  225-EE Burden of Chronic Obstructive Pulmonary Disease (COPD) Healthcare Costs in Patients with Moderate-to-Severe Disease Ali Siddiqui Received Received
  227-PCR A Real-World Longitudinal Study Characterizing the Impact of Fatigue in Adults With Relapsing Multiple Sclerosis Gilda Teissier Received Received
  230-EPH Geographic Variation in Routine Childhood Vaccination Using Real-World Evidence: Pre- and Post- COVID-19 Pandemic Jasmine Watson Received Received
  231-MSR Searching Clinical Trial Registries in Systematic Literature Reviews (SLR): Which and Why? Lalith Mittal Received Received
  232-HPR Eurocover-CLL: Reimbursement and Accessibility for New Treatments in Relapsed/Refractory Chronic Lymphocytic Leukemia in Central and Eastern Europe Magdalena Monica Received Received
  237-PCR Patient Activation and Health Outcomes in Spinal Surgery: A Systematic Literature Review of Measures, Effects, and Strategies Mehdi Zahra Received Received
  239-EPH Positive Airway Pressure (PAP) Therapy in Obstructive Sleep Apnea (OSA): Modeling of 20 Year Mortality and Hospitalizations Ankit Ghildiyal Received Received
  239-PCR Comparative EQ-5D Utilities for Valoctocogene Roxaparvovec Gene Therapy and Emicizumab in People With Severe Hemophilia A Using a Matching-Adjusted Indirect Comparison Milad Karimi Received Received
  241-EE Fondaparinux: A Cost-Saving Alternative to Low-Molecular-Weight Heparins for Venous Thromboembolic Event Prevention/Treatment and Acute Coronary Syndrome Treatment Henning Austrup Received Received
  242-HPR Lump-Sum Envelopes: High Predictability for Payers (Healthcare Product Pricing Committee CEPS) and Minor Contribution for Companies Philippine Poignant Received Received
  243-HTA Mixture Cure Model in HTA Submissions: A Comparative Review Yan Zhi Tan Received Received
  244-HPR Innovative Reimbursement Agreements Addressing the Challenges of Advanced Therapy Medicinal Products: Systematic Review for the Five Major European Healthcare Systems (EU5) Roman Spelsberg Received Received
  245-EE Economic Burden in Patients With Chronic Myeloid Leukemia in Early Lines of Therapy: A Literature Review Isabelle Lundqvist Received Received
  248-EPH Age-Adjusted Years of Potential Life Lost (YPLL) Rates Due to Ovarian Cancer in Chile During 2002-2019 Abbas Ali Received Received
  249-PCR Use of Digital Methods to Collect Real-World Data in Participants With Psoriatic Arthritis Treated With the IL-23 Inhibitor Guselkumab or IL-17 Inhibitors: Baseline Characteristics From the eDaily PsABIond Sub-Study Fiona Allum Received Received
  253-PCR Visualizing Risk: Risk Graphics Impact on Patient Understanding and Choices in Preference Studies Stella Marceta Received Received
  259-PCR Life and Work Productivity Impairment in Adult Continuous Glucose Monitor Users With Type 1 Diabetes: Results From a Cross-Sectional Survey Study Zara Petzoldt Received Received
  261-EE Economic Evaluation of Dupilumab Versus Standard of Care for the Treatment of Adult Patients With Moderate-to-Severe Prurigo Nodularis in the United States Caitlyn Matuska Received Received
  262-EE Cost-Consequence Analysis of Cabozantinib in Combination With Nivolumab in Treatment of First-Line Advanced Renal Cell Carcinoma in Germany: A Payer Perspective Julia Stiefel Received Received
  266-PCR Saliency Versus Ranking: Exploring the Utility of Tasks Used in Qualitative Research to Identify Concepts That Are Most Important to Patients Catherine Bottomley Received Received
  268-EPH Private market uptake of varicella vaccination and related sociodemographic differences: A Danish nationwide observational study Mette Boie Steffensen Received Received
  268-EE Interim Burden of Disease Findings for Myasthenic Gravis-Resource Utilization Epidemiology, Survival, and Treatment Patterns (MG-REST) Study in Ontario, Canada Kobina Quansah Received Received
  268-HTA Exploring Potential: Performing Multi-Criteria Decision Analysis (MCDA) on Orphan Drugs in the Dutch Context Ellen Anna Kok Received Received
  271-PCR Mindful Measures: Assessing Content Validity of Patient-Reported Outcomes for Major Depressive Disorder in Clinical Trials Daniella Olonilua Received Received
  275-EPH Treatment Patterns and Patients Pathways in Actinic Keratosis Population: A Retrospective Longitudinal Cohort Study in the French National Health Insurance Claim Database (SNDS)EPIKA Study Adam DOBLE Received Received
  277-PCR Patients Perspective of the Access to and Quality of Care for Chronic Kidney Disease: Insights From the DISCOVER-CKD Qualitative Study Ewelina Palmer Received Received
  277-EE Cost of Stroke in Latin America: A Multicentric Time-Driven Activity-Based Costing Study Luiza Dittrich Received Received
  282-HTA The NICE QALY Severity Modifier: What Have We Learned So Far Jasmine Watson Received Received
  283-PCR Through Their Eyes: Defining Good Life in Dementia for Health Economics Outcome Measures Irina Kinchin Received Received
  283-EE Number of Needed to Treat (NNT) to Achieve Seizures Reduction or Seizure Freedom in Dravet Syndrome in France: Results From an Itc of Stiripentol vs Fenfluramine and Cannabidiol and the Economic Implications Marie Fourcroy Received Received
  285-PCR Quality of Life in Early-Stage Chronic Kidney Disease: A Targeted Literature Review Amit Ahuja Received Received
  286-PCR Targeted Literature Review to Explore the Patient Experience of Hemolytic Disease of the Foetus and Newborn (HDFN) Jennifer Norma Barthelmes Received Received
  288-EPH Characteristics of NASH Patients Who Develop Hepatocellular Carcinoma (HCC) With and Without a Corresponding Cirrhosis Diagnosis Yestle Kim Received Received
  289-EPH Effect of Anti-Rheumatic Drugs on Diabetic Foot Disease Among Patients With Type 2 Diabetes and Rheumatoid Arthritis Zhaonan Wang Received Received
  290-PCR Characterizing Fatigue in US, European, and Latin-American Adults With Relapsing Multiple Sclerosis: A Real-World Study Conducted Using a Novel Disease Specific Scale Teissier Gilda Received Received
  291-EE Integrating a Markov Chain Monte Carlo Convergence Diagnostics Output Analysis (CODA) Into State Transition Cost-Effectiveness Models in Microsoft Excel: A Stepwise Approach Colleen Dumont Received Received
  292-EE Cost-Effectiveness Analysis of PCV20 31 Versus PCV15 21 Vaccination of the Pediatric Population in the Netherlands Michel Peters Received Received
  293-EE Cost-Effectiveness of Diagnostic Testing for Hepatitis Delta in the United Kingdom Mirko von Hein Received Received
  302-HTA Consideration of Societal and Equity-Based Value Attributes (VAs) by the National Institute for Health and Care Excellence (NICE) During Evaluation of Innovative Technologies in 2023 Michael Tang Received Received
  304-HTA Is the New EU HTA Process Fit for Engagement of Patients With Rare Diseases? Gavin Outteridge Received Received
  305-HTA Development of a Stepwise Approach to Assessing the Feasibility of Conducting a Distributional Cost-Effectiveness Analysis Maisie Borrows Received Received
  306-EE Comparison of Methods for Extrapolation of Drug Survival of Biologics in Psoriasis NICE Submission Cost-Effectiveness Analyses Paulina Kazmierska Received Received
  306-PCR Exploring the Difference That Patient Involvement in HTA Makes in Cancer Peter Wagner Received Received
  307-EE Comparing Ancillary Services Associated With Subcutaneous Versus Intravenous Medication Administration Phillip Sarocco Received Received
  311-EE Evaluating the Cost-Effectiveness of Ruxolitinib for the Treatment of Polycythaemia Vera Patients That Are Resistant/Intolerant to Hydroxycarbamide/Hydroxyurea in England and Wales rachid rafia Received Received
  315-PCR Labeling Risk: Comparing Occurrence vs Severity-Based Risk Labels in Patient Preference Studies Stella Marceta Received Received
  316-PCR Utility Values for Endoscopy and Symptoms-Based Health States in Crohns Disease: Analysis of Data From a Phase 3 Randomized Controlled Clinical Trial Susanne Hartz Received Received
  318-PCR Unmet Needs of Patients With Severe Von Willebrand Disease and Their Caregivers: A Qualitative Study on Current Standard of Care in Canada Tiffany Cristarella Received Received
  320-HTA How to Manage the Multiple PICOs and Challenging Timelines in Systematic Reviews for JCA Submissions SOHAN DESHPANDE Received Received
  320-PCR Real-World Quantitative Insights of Cancer Patient Experience With Subcutaneous (SC) Vs Intravenous (IV) Drug Delivery Phillip Sarocco Received Received
  325-HTA Stakeholder Perspectives on the Draft Implementation Act for Joint Clinical Assessments: Key Insights and Concerns Trisha Whitney Received Received
  336-EE Real-World US Optum Claims Database Study of Pre- and Post-Relapse Costs and Health Care Resource Utilization (HCRU) in Patients With High-Risk Localized or Locally Advanced Prostate Cancer (HR-LPC/LAPC) Who Relapsed Kim Buscemi Received Received
  336-HTA Evaluation of Rejected Reimbursement Decisions in NICE and CADTH Submissions for Non-Small Cell Lung Cancer Colleen Dumont Received Received
  337-EE Cost-Effectiveness of 177LuLu-PSMA-617 in Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer Caitlyn Matuska Received Received
  339-EE Cost and Healthcare Resource Utilization (HRU) Among Patients Living with Angelman Syndrome (AS): A Systematic Review Vyshnavi telukuntla Received Received
  342-EE The Budget Impact of Introducing an Arterial Blood Gas Syringe With or Without an Automatic Blood Gas Analyzers in Intensive Care Unit in China xinyue liu Received Received
  343-HTA Reduced Access to Pharmaceuticals in the Nordics: Can It be Explained? Jenny Wiberg Received Received
  343-EE Cost-Effectiveness Analysis of Resmetirom for the Treatment of Adults With Noncirrhotic NASH and Moderate-to-Advanced Liver Fibrosis in the US: Integrating the Dual NASH Resolution and Fibrosis Improvement Endpoints Yestle Kim Received Received
  348-HTA Development and Proof-of-Concept Study of a Life-Cycle Prioritization Framework for Oncology Product Innovation Deirdre Weymann Received Received
  348-EE Number Needed to Treat and Cost-per-Responder Analysis of Dupilumab and Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps G Kaushik Subramanian Received Received
  352-EE Cost-Effectiveness of Chikungunya Vaccination With IXCHIQ in Adults in Puerto Rico Adrianne de Roo Received Received
  352-HTA The Benefits and Challenges of Streamlined NICE Cost Comparisons Carina Marie Behr Received Received
  353-HTA Developing Economic Evaluation Guidelines for Saudi Arabia Local Experts Engagement Fatma Maraiki Received Received
  358-HTA Access to Innovative Therapies in Rare DiseasesEvaluation Challenges of Single Arm Trials With External Control Arm: FDA Versus French Has Evaluations Between 2018 and 2024 Haifa BEN ROMDHANE Received Received
  360-HTA Acceptability of Real-World Evidence by European HTA bodies to Support Value Assessments of Rare Disease Therapies Richard Massey Received Received
  365-EE Economic Evaluation of Transcatheter Aortic Valve Implantation (TAVI) Relative to Other Interventions in Cardiovascular and Oncology Disease Areas: A Targeted Literature Review Archita Sarmah Received Received
  366-HTA Challenges and Criteria for Accepting Lower-Level of Evidence in Early Benefit Assessments (EBA) in Germany Jörg Tomeczkowski Received Received
  367-EE Health Care Resource Utilization and Costs Among Patients With Severe Hypertriglyceridemia and Acute Pancreatitis or Major Adverse Cardiovascular Events Susannah Hershberg Received Received
  368-EE Angiotensin II (ANGII) Reduces Intensive Care Unit (ICU) Length of Stay Providing Cost Savings in the Treatment of Refractory Distributive Shock (DS) Attila Mihalik Received Received
  374-EE Transcatheter Aortic Valve Implantation vs Surgery in Symptomatic Severe Aortic Stenosis Patients at Low Surgical Mortality Risk in Belgium: An Updated Cost-Utility Analysis Based on the 5-Year Data From the Partner 3 Trial Archita Sarmah Received Received
  378-EE Health Economic Impact of Maternal Bivalent Stabilized Prefusion F Subunit Vaccine for Prevention of Respiratory Syncytial Virus Infections Among Infants in Germany Ahuva Averin Received Received
  380-EE A Case Study of Real-World Health Resource Utilization and Costs in a Patient With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2), an Ultra-Rare Pediatric Disease Charlotte Camp Received Received
  381-HTA Using Artificial Intelligence (AI) to Extract National Institute for Health and Care Excellence (NICE) Final Appraisal Documents (FAD): Evaluating the Potential Application of Large Language Models (LLM) vs Human Extraction Michael Tang Received Received
  385-HTA Psychological Aspects of Payer Decision-Making in Healthcare: Which Attitude Components Drive Decisions and How Can These Be Influenced? Lucy Nelson Received Received
  386-EE Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against Il-17A, Il-12/23 and Il-23 Inhibitors for the Treatment of Psoriatic Arthritis in Finland Jenny Wiberg Received Received
  388-HTA Outcomes and Costs in Specialized Burn Care: Validation of the Quality Cost Indicator Model for Specialized Burn Care Raaba Shagari Miriyam Thambithurai Received Received
  394-HTA Exploring PICO Variations in the Context of the European Joint Clinical Assessment Sakshi Jindal Received Received
  403-HTA Access to Modulating Drugs for Cystic Fibrosis Sybelle Drumond Received Received
  403-EE The Cost-Effectiveness of Axicabtagene Ciloleucel Versus Standard of Care As Second-Line Therapy in Patients With Large B-Cell Lymphoma in Germany Florian Kron Received Received
  404-EE Cost-Effectiveness of Rapid Direct Multiplex PCR Test for Diagnosing Meningitis and Encephalitis From the Brazilian Public Perspective sophie vandepitte Received Received
  404-HTA Use of Real-World Evidence in HTA Submissions in Emerging Markets Tanja Babic Received Received
  405-HTA Taxonomy of the Full Value of mRNA Influenza and COVID-19 Combination Vaccines Joseph Knee Received Received
  410-HTA Generative AI: A Novel Approach to Data Extraction for NMAS in EU JCA Cheryl Jones Received Received
  414-EE The Cost-Effectiveness of Axicabtagene Ciloleucel Versus Standard of Care As Second-Line Therapy in Patients With Large B-Cell Lymphoma in the Netherlands Angela Borghouts- de Ruijter Received Received
  419-EE Systematic Literature Review of Cost-Effectiveness Evaluations of Freestyle Libre Continuous Glucose Monitoring Systems Jack Timmons Received Received
  421-EE A Budget Impact Analysis of Azelastine Hydrochloride/Fluticasone Propionate (AzeFlu) Nasal Spray Suspension for Patients With Allergic Rhinitis (AR) in the Kingdom of Saudi Arabia Jatin Agarwal Received Received
  432-EE Number Needed to Treat and Associated Costs/Additional Responder of Dupilumab Versus Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis G Kaushik Subramanian Received Received
  433-EE Cost Effectiveness Evidence Overview for Metformin and SGLT2is in Type 2 Diabetes Patients With Cardiorenal Risk: A Targeted Literature Review Julian Dettenbach Received Received
  439-EE A Multiple Myeloma Case Study for Incorporating Carbon Footprint in Health Technology Assessment Ruth Chapman Received Received
  440-EE Cost-Effectiveness of Bioabsorbable Nasal Implant (Latera) Versus Conservative Management for the Treatment of Nasal Airway Obstruction (NAO) Tahlia Seage Received Received
  452-EE Cost Calculator of Immunotherapies in the 1L Endometrial Cancer Treatment From the Brazilian Private Healthcare System Perspective Abbas Ali Received Received
  453-EE Clinical and Economic Benefits of Adopting Cladribine Tablets for the Treatment of Relapsing: Remitting Multiple Sclerosis in Public Health Service Institutions in Mexico Margarita Fuentes Received Received
  465-EE The Impact of Time-Dependent Events on Semi-Markov Models With Treatment Sequencing: A Simulation Study Colleen Dumont Received Received
  467-EE A Cost-Effectiveness Analysis Comparing Two PFO Occluder Devices Using a Markov Model Simulation Over a 5-Year Time Horizon From a Match-Adjusted Indirect Treatment Comparison Mitesh Nakum Received Received
  471-EE Identifying the Value Drivers in Obesity Treatment: A Targeted Review of Weight Loss Effects on Health Economic Outcomes Caitlyn Matuska Received Received
  479-EE Real-World Evidence of Healthcare Utilization and Costs for Type 1 Diabetes and Severe Hypoglycemia by Age in Germany Zara Petzoldt Received Received
  484-EE Evaluating the Cost-Effectiveness of Dabrafenib and Trametinib for the Treatment of Pediatric Patients With Relapsed or Refractory High-Grade Glioma in England and Wales rachid rafia Received Received
  485-EE Exploring the Impact of Changes in Health Valuation Post-COVID-19 Pandemic on an Existing Cost-Effectiveness Analysis Jasmine Watson Received Received
  492-EE Cost-Effectiveness of CDK4/6 Inhibitors (CDK4/6i) in First- vs Second-Line for Advanced Breast Cancer in the Phase 3 SONIA Trial (BOOG 2017-03) Seamus Kent Received Received
  496-EE Relugolix/Estradiol/Norethisterone Compared to Tranexamic Acid for Symptomatic Uterine Fibroids in Premenopausal Women (20 to 40 YEAR Old): A Cost-Utility Analysis Siu Suen Wong Received Received
  499-EE Health Resource Utilization (HRU) and Costs of Patients With Relapsed/Refractory Multiple Myeloma (RRMM) in the United States (US): A Systematic Literature Review Pardis Lakzadeh Received Received
  502-EE Prevalence, Cost, and Per-Patient Economic Burden of Hospital-Onset Bacteremia and Fungemia Timothy Kelly Received Received
  503-EE Key Features of Economic Models Used in Submissions to NICE in Dermatology Indications Caitlyn Matuska Received Received
  505-EE Cost-Effectiveness Analysis of Contemporary Advanced Prostate Cancer Management: A Markov Model for the Canadian Context Valentyn Litvin Received Received
  508-EE Number Needed to Treat and Cost-per-Event Avoided for Dupilumab Versus Other Asthma Biologics for the Treatment of Moderate-to-Severe Asthma Kaushik SUBRAMANIAN Received Received
  511-EE Impact of Delayed Treatment Initiation With Resmetirom in Patients With Noncirrhotic Non-Alcoholic Steatohepatitis (NASH) With Moderate to Advanced Fibrosis Yestle Kim Received Received
  517-EE Cell-Free DNA Epigenomic-Based Test Is Predicted to Be Cost-Effective to Manage New-Onset Type 2 Diabetes Patients for Risk of Pancreatic Cancer Adrian Vilalta Received Received
  519-EE Cost-Effectiveness Analysis of Osteosarcoma Treatment: Insights From a Systemic Literature Review Aikyadeep Mandal Received Received
  528-EE Cost-Effectiveness Analysis of the TAK-003 Dengue Vaccine Introduction in Argentina Laura Brion Received Received
  532-EE Budget Impact Analyses of Hemoglobin a1C and Lipid Panel Point-of-Care Testing With Afinion 2 in Italy and Canada Trisha Whitney Received Received
  533-EE Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Low Surgical Risk Symptomatic Severe Aortic Stenosis Patients in Brazil Archita Sarmah Received Received
  536-EE The Benefit of Introducing Remimazolam for General Anesthesia in Belgian Clinical Practice Attila Mihalik Received Received
  540-EE Cost-Effectiveness of Next Generation Sequencing to Select Microsatellite Stable/Mismatch Repair Proficient Metastatic Colorectal Cancer Patients for Immune Checkpoint Inhibitor Therapy Benjamin Peter Geisler Received Received
  542-EE Long-Term Extrapolation of Overall Survival (OS) and Progression-Free Survival (PFS) for the Lunar Trial in Metastatic Non-Small Cell Lung Cancer (NSCLC) Following Progression on Platinum-Based Therapy Fernando Nino de Rivera Received Received
  543-EE Hospital Healthcare Resource Utilization in People With Cystic Fibrosis Treated With Elexacaftor/Tezacaftor/Ivacaftor in Portugal: A Non-Interventional, Retrospective Study Shivali Arora Received Received
  562-EE Public Health Impact and Cost-Effectiveness of Replacing PCV13 With PCV15 in the National Immunization Program in Saudi Arabia Ghadah Albassam Received Received
  566-EE Real-World Evidence of Multi-Gene Panel Sequencing Effectiveness and Cost-Effectiveness for Advanced Cancers: A Tumor-Agnostic Target Trial Emulation Emanuel Krebs Received Received
  580-EE Cost-Utility of Acromegaly Second Line Pharmacological Treatments in Adult Patients in France Haifa BEN ROMDHANE Received Received
  601-EE Using Dupilumab in Line With the England NICE Recommendation (TA534): Impact on the Healthcare Resource Utilization and Non-Medicine Cost G Kaushik Subramanian Received Received
  602-EE Cost-Effectiveness of Universal Screening for Hypothyroidism in Pregnant Women in Indonesia and Mexico Julian Dettenbach Received Received
  616-EE Cost of Illness Study of Inherited Retinal Diseases in the Netherlands in 2023 Loek Lennaerts Received Received
  631-EE Cost-Effectiveness of Difelikefalin Compared to Best Supportive Care for Treatment of Chronic Kidney Disease-Associated Pruritus in Australia Scott Brydon Received Received
  638-EE Long COVID: A Costly Condition Imposing Substantial Burden on Society Naomi Stapleton Received Received
  643-EE Assessing Healthcare Payer Perspective on Health Economic Model Transparency and Applicability to Own Setting Oleksandr Topachevskyi Received Received
  648-EE Micro-Costing Study of Comprehensive Genomic Profiling for Implementation of Precision Cancer Medicine in Public Healthcare Systems: The Norwegian Infrastructure for Precision Diagnostics and Impress-Norway Trial Pia Sofie Henkel Received Received
  651-EE Evaluating the Cost-Effectiveness of Dabrafenib and Trametinib for the Treatment of Pediatric Patients With Low-Grade Glioma Requiring Systemic Treatment in England and Wales Rachid Rafia Received Received
  668-EE Assessing the Impact of a Virtual Maternity Care Program on Total Cost of Care in a US Medicaid-Insured Population Sara Crow Received Received
  669-EE Analysis of the Costs and Carbon Footprint Associated With Reusable Flexible Cystoscopes: Implications for the Utilization of Single-Use Digital Flexible Cystoscopes Timothy Kelly Received Received
  670-EE Impact of Different Mapping Algorithms From Disease-Specific Measures to EQ-5D on Cost-Effectiveness Analysis in Atopic Dermatitis Tomohiro Kondo Received Received
  676-EE Economic Burden and Unmet Needs of Retinitis Pigmentosa: Expert Perspective in Brazil and Mexico Yann Boixel Received Received
  685-EE What Is the Real Price of Switching Medical Technologies? Evaluation of Financial and Value-Based Aspects: The Case for Dialysis Sophie Boeger Received Received
  690-EE The Impact of Caring for an Infant With Respiratory Syncytial Virus on Work-Related Outcomes: Insights From Caregivers Recruited From Canada, Germany, Italy, and Netherlands Nemin Chen Received Received
  699-EE The Benefit of Introducing Remimazolam for Procedural Sedation in Belgian Clinical Practice Attila Mihalik Received Received
  708-EE Assessment of Direct Costs of Human Papillomavirus Related Diseases in Saudi Arabia Carole Mamane Received Received
  714-EE Identifying Patients With High Economic Burden Using Real-World Data: The Case of Myasthenia Gravis (MG) Ingrid Schager Received Received
  717-EE Influence on Antibiotic Prescribing and Cost Effects Through Standardized Implementation of PoC Testing in Adults With Sore Throats in Standard SHI Care Jana Schlosser Received Received
  725-EE Cost-Effectiveness of Linzagolix for Uterine Fibroids in Australia: A Healthcare Payer and Societal Perspective Tahlia Seage Received Received
  727-EE Determining Survival Impact and Cost-Effectiveness of Multi-Gene Panel Sequencing in Metastatic Colorectal Cancer With Super Learning Approaches Emanuel Krebs Received Received
  730-EE Health Care Resource Utilization (HCRU) in Chronic Obstructive Pulmonary Disease (COPD), and Asthma Patients With Moderate-to-Severe Disease Ali Siddiqui Received Received
  738-EE Economic Value of Dupilumab and Advanced Therapeutics in Patients With Type 2 Inflammatory Diseases in Italy: An Estimation of Healthcare Resource Utilization Cost Offsets Ali Siddiqui Received Received
  740-EE Cost-Effectiveness of Glycopyrronium Bromide Oral Solution for the Management of Severe Sialorrhea in Children With Cerebral Palsy in Poland Grzegorz Binowski Received Received
  741-EE Budget Impact Analysis of Risdiplam in the Treatment of Newborn Spinal Muscular Atrophy Patients in Poland Grzegorz Binowski Received Received
  749-EE Socioeconomic Disparities in Hypertension Medication Adherence in Quezon City: A Cross-Sectional Study Ina Mulingbayan Received Received
  759-EE Cost-Effectiveness of Tezepelumab in Taiwan for Severe Asthma Nora Lin Received Received
  774-EE Growth and Economic Trends of European CROs: Insights From the EUCROF Benchmarking Project Hedda Magnusson Received Received
  790-EE Cost-Effectiveness and Cost Utility Analysis of an eHealth Peer-Led Wheelchair Training Program Compared to the Existing Wheelchair Training Practice in Canadian Rehabilitation Centers: Economic Evaluation of a RCT Maude Laberge Received Received
  791-EE Cost-Effectiveness Analysis of 1.5 Ruxolitinib Cream for the Treatment of Patients With Atopic Dermatitis in Canada Mehdi Larbi Received Received
  794-EE Assessing the Impact of Introducing Mavacamten for the Treatment of Obstructive HCM on the Modelled System and Societal Level Burden in China JIA YU Received Received
  803-EE Systematic Review of Healthcare Costs and Resource Utilization in Fibromyalgia in European Countries and the US Nidhun Praveen Received Received
  814-EE Potential return on subscription to smart phone based digital health risk assessment Laura Wilson Received Received
  824-EE Are Standard Economic Evaluations Suitable for Evaluating Life-Extending Innovations in Kidney Care? Sophie Boeger Received Received
  829-EE Quantifying Disease-Specific Indirect Economic Burden Using Survey Research Methods as a Component of Estimating the Total Economic Burden of a Disease Jasmine Watson Received Received
  832-EE The Lifetime Return on Investment of Measles, Mumps, and Rubella Vaccination in Belgium and Poland Ugne Sabale Received Received
  835-EE Improper Age-Adjustment of Health State Utilities in Cost-Effectiveness Models: Assessing the Impact and Key Drivers Walter Morris Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
04:06
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

ISPOR Europe 2024

 

17-20 November Barcelona
FAQs


Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert